Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121721492 | 12172149 | 2 | F | 201602 | 20160720 | 20160311 | 20160801 | EXP | US-ACTELION-A-NJ2016-132669 | ACTELION | 79.00 | YR | E | F | Y | 0.00000 | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121721492 | 12172149 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 62.5 MG, BID | DP061P0112, NP013P0402, NP014P0201 | 21290 | 62.5 | MG | TABLET | BID | |||||
| 121721492 | 12172149 | 2 | C | OXYGEN. | OXYGEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121721492 | 12172149 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121721492 | 12172149 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121721492 | 12172149 | Cerebrovascular accident | |
| 121721492 | 12172149 | Fall | |
| 121721492 | 12172149 | Oesophageal injury | |
| 121721492 | 12172149 | Procedural complication | |
| 121721492 | 12172149 | Ventricular assist device insertion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121721492 | 12172149 | 1 | 20090810 | 0 |